John Townsend
Net worth: - $ as of 30/06/2026
Net worth: - $ as of 30/06/2026
John W.
Townsend is Chief Financial Officer at Unicycive Therapeutics, Inc. since 2021.
Formerly, Mr. Townsend was Chief Accounting Officer at Plus Therapeutics, Inc. in 2015.
From 2017 to 2020, Mr. Townsend was Chief Accounting Officer & Controller at Guardion Health Sciences, Inc. Mr. Townsend completed an undergraduate degree at San Diego State University in 1993.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Director of Finance/CFO | 01/03/2021 |
| Companies | Position | End |
|---|---|---|
| GUARDION HEALTH SCIENCES, INC. | Comptroller/Controller/Auditor | 02/09/2020 |
| PLUS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30/06/2015 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc. Pharmaceuticals: OtherHealth Technology Develops and distributes food & dietary supplements | Health Technology |
Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions